Ryota Kanemaru

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Motoyasu Kato, Takehito Shukuya, Fumiyuki Takahashi et al. · BMC Cancer · 2014 · 55 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis

Ryota Kanemaru, Fumiyuki Takahashi, Motoyasu Kato et al. · Lung · 2018 · 23 citations

Medicine, Cell Biology, Oncology +16

Cerebral infarction in advanced non-small cell lung cancer: a case control study

Motoyasu Kato, Takehito Shukuya, Keita Mori et al. · BMC Cancer · 2016 · 20 citations · Full text

Medicine, Oncology, Surgery +15

LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer

Takanobu Jotatsu, Shigehiro Yagishita, Ken Tajima et al. · Biochemistry and Biophysics Reports · 2016 · 18 citations · Full text

Medicine, Molecular Biology, Oncology +16

Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study

Kota Nakamura, Motoyasu Kato, Takehito Shukuya et al. · BMC Cancer · 2017 · 14 citations · Full text

Medicine, Oncology, Pharmacology +15